跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 642 条关于
“BA.5.2.6”
全部
642
临床试验
215
药物
117
机构
242
资讯
68
3年前
FDA Restricts Emergency Use Authorization for AstraZeneca's Evusheld in the US
去年
FDA Limits GSK's Xevudy Authorization Due to BA.2 Variant Concerns
去年
Beyond Air's NeuroNOS Receives FDA Orphan Drug Designation for Glioblastoma Therapy BA-101
4年前
FDA Restricts Sotrovimab Use Due to Omicron BA.2 Variant Resistance
去年
FDA Revokes Authorization of GSK and Vir's Sotrovimab Due to BA.2 Inefficacy
去年
Pfizer and BioNTech Seek FDA Authorization for COVID-19 Vaccine in Young Children
9个月前
US FDA Updates Safety Reporting Guidelines for Bioavailability and Bioequivalence Studies, Indian Pharma Industry Responds Positively
3天前
India's DTAB Proposes Amendment to NDCT Rules to Add GMP Requirements for Trial Batches
去年
Bovhyaluronidase Azoximer Shows Promise in Treating Pulmonary Sequelae of COVID-19
3年前
FDA Withdraws Original COVID-19 Vaccine Authorization, Focuses on Bivalent Boosters
第 1 页,共 7 页
上一页
下一页